Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-000438
Filing Date
2020-01-08
Accepted
2020-01-07 21:43:02
Documents
4
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k010820_immuronlimited.htm 6-K 12630
2 IMMURON CEO TO PRESENT AT BIOTECH CONFERENCE IN SFO f6k010820ex99-1_immuron.htm EX-99.1 10403
3 GRAPHIC image_001.jpg GRAPHIC 1395
4 GRAPHIC ex99-1_001.jpg GRAPHIC 19105
  Complete submission text file 0001213900-20-000438.txt   52558
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 20514450
SIC: 2834 Pharmaceutical Preparations